A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)

• Status: Terminated
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Plasmin is expected to create a posterior vitreous detachment (PVD) when injected directly into the eye. The pharmacological creation of a PVD may be beneficial in helping to treat a variety of conditions.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Fibrinolysin

Criteria

Inclusion Criteria:

• Patients who are in need of a vitrectomy.

Exclusion Criteria:

• A PVD in the study eye as assessed by the investigator using ophthalmic and alternative examination techniques.

• A history of vitrectomy in the study eye.

• A media opacity that precludes quality examination of the vitreous and fundus in the study eye.